Aethlon Medical
AEMD
7 hedge funds and large institutions have $2.3M invested in Aethlon Medical in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
16% more capital invested
Capital invested by funds: $1.98M → $2.3M (+$317K)
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$64.7K |
Top Sellers
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$16K |
| 2 |
AIG
American International Group
New York
|
-$5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
AEMD Hedge Fund Activity: Q2 2016 in Review
7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2016, worth a combined $2.3M — up 16% from $1.98M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new AEMD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $64.7K. The largest seller was Thompson Davis & Co, cutting an estimated $16K.
- 7 institutional investors held Aethlon Medical (AEMD) as of Q2 2016, up from 6 in Q1 2016.
- Funds reported $2.3M of Aethlon Medical stock for Q2 2016, up 16% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q2 2016 and 0 closed out, a net change of +1 holder.
- The largest Aethlon Medical buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $64.7K added.
- The largest Aethlon Medical seller in Q2 2016 was Thompson Davis & Co, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2016.